""WATCH ME GROW PEDIATRICS, LLC""
3586 ALOMA AVE STE 2
Colorado
United States
John Jesitus is a medical writer based in Westminster, CO.
March 04, 2021
With up to 30% of pediatric health care visits involving skin complaints and fewer than 400 board-certified pediatric dermatologists in the United States, teledermatology offers a valuable tool for increasing access and cutting wait times.
March 03, 2021
This is the first overhaul in a quarter century that simplifies evaluation and management and increases flexibility.
According to one expert at the 29th European Academy of Dermatology and Venereology Virtual Congress, trichoscopy (a dermoscopy-based diagnostic method) not only helps diagnose hair disorders and monitor treatment but also predicts treatment efficacy.
February 25, 2021
Several universal gaps in diagnosis and treatment of atopic dermatitis (AD) as well as real-world interventions for improvement are the focus of a ground-breaking report.
February 11, 2021
Topical probiotics show promise in treating various skin diseases including acne, but more research is needed.
January 12, 2021
A recent study shows an association between finasteride use and psychological adverse events (AEs) including suicidality. Dermatologists should weigh benefits and risks carefully when considering finasteride for certain patients with hair loss, according to one expert.
December 18, 2020
A vast majority of patients with atopic dermatitis (AD) are satisfied with dupilumab (Dupixent, Sanofi and Regeneron) treatment, according to research presented at the European Academy of Dermatology and Venereology (EADV) Virtual Congress.
December 17, 2020
A new innovative report identifies gaps and offers solutions for improving quality of care in atopic dermatitis (AD).
Highlighting the relationship between long-term safety and drug survival, a recent review may help address physician reluctance in prescribing conventional systemic psoriasis treatments.
December 16, 2020
Half of patients are satisfied with their atopic dermatitis treatment and more than half of patients worry about topical steroid side effects, addiction and withdrawal, according to a recent study.